Skip to content
PICO Portalanswers from OpenAlex

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

PaperCitations, authors & open-access status

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is a paper indexed in PICO Portal from OpenAlex.

How many citations does AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial have?

PICO Portalcitation count

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial has 675 citations in the OpenAlex counts PICO Portal stores.

When was AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial published?

PICO Portalyear

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial has 2011 year in the PICO Portal index.

What is the open-access status of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

PICO Portaloa status

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial has closed oa status in the PICO Portal index.

What is the DOI of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

PICO Portaldoi

The DOI for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is on the source record.

What is the PMID of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

PICO Portalpmid

The PMID for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is on the source record.

What is the OpenAlex record for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

PICO Portalopenalex

The OpenAlex for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial